Indonesia Contraceptive Devices Market Report 2022 to 2030

Indonesia Contraceptive Devices Market Analysis

$ 3999

Indonesia's Contraceptive Devices Market is expected to witness growth from $77 Mn in 2022 to $143 Mn in 2030 with a CAGR of 8.00% for the forecasted year 2022-30. By 2050, the population of Indonesia is going to increase to 305 million from its current size. The need for contraceptive devices is anticipated to rise along with the population. The market is segmented by type and by gender. Some key players in this market include DKT Indonesia, Kimia Farma, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

ID: IN10IDMD005 CATEGORY: Medical Devices GEOGRAPHY: Indonesia AUTHOR: Jigyasu Bhandari

Buy Now

Indonesia Contraceptive Devices Healthcare Market Executive Analysis

Indonesia's Contraceptive Devices Market size is at around $77 Mn in 2022 and is projected to reach $143 Mn in 2030, exhibiting a CAGR of 8.00% during the forecast period. Indonesia plans to spend $30.18 billion more on healthcare between 2022 and 2028. In 2028, spending is anticipated to reach $69.3 billion. Indonesia is regarded as a middle-income country that is only beginning to industrialise. It is the seventh-largest economy in the world in terms of GDP, although nominal GDP ranks it in 17th place. By 2025, Indonesia's $40 billion Internet market is anticipated to reach $130 billion.

In Indonesia, there were 177 maternal deaths per 100,000 live births in 2021. This indicates that in that year, 7,500 women died as a result of difficulties linked to pregnancy or childbirth. In Indonesia, there will be 640,000 HIV/AIDS patients by 2021. Unintended pregnancies can be avoided with the help of contraceptive methods like condoms, intrauterine devices, and oral contraceptives. This aids women and couples in family planning and helps them avoid unplanned pregnancies that could result in mother and infant mortality, illness, and financial hardship. By lowering the risk of STIs and unintended pregnancies, which can lower the risk of unsafe abortions and maternal mortality, contraceptive methods also assist in promoting reproductive health. Indonesia offers a range of contraceptive methods, including condoms, IUDs, hormonal implants, and oral contraceptives. Because of this, women and couples have a variety of options to select from that may be tailored to their interests, health, and lifestyle. Particularly when compared to the expenditures of unwanted pregnancy and childbirth, contraceptive methods are cost-effective. Purchasing contraceptive devices can lessen the strain on the healthcare system and advance economic growth in Indonesia, where the population is huge and the healthcare system is underfunded.

Indonesia Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

By 2050, the population of Indonesia is going to increase to 305 million from its current size. The need for contraceptive devices is anticipated to rise along with the population. The Indonesian government has started a number of programmes to encourage family planning and lower the high fertility rate of the nation. These programmes involve giving away free contraceptives, encouraging people to use them, and enhancing reproductive health care. Manufacturers are creating cutting-edge contraceptive methods that are more efficient, secure, and simple to use. It is anticipated that these technological developments would accelerate the market's expansion. In Indonesia, more people are choosing contraceptive methods as a result of rising understanding of reproductive health issues and the value of family planning. The market is anticipated to grow even more as a result of this trend in the years to come.

Market Restraints

One of the main challenges faced by manufacturers in Indonesia is the lack of knowledge and understanding among the people, especially in rural areas, regarding the need for family planning and the numerous types of contraceptive devices available. As a result, the market may grow more slowly and there may be less of a need for specific products. Due to cultural and religious restrictions, it's possible that modern contraception techniques aren't frequently used in Indonesia. For instance, some people could believe that utilising contraceptives is immoral or unethical. The cost of contraceptive techniques may be a major barrier to access for many people in Indonesia, especially those who are poor.

Competitive Landscape

Key Players

DKT Indonesia (ID)
Kimia Farma (ID)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

The National Agency of Drug and Food Control (BPOM) is Indonesia's regulatory authority in charge of controlling contraceptive devices. To ensure the efficacy and security of contraceptive devices, it supervises their registration, licencing, and post-market surveillance. The Ministry of Health (MoH) of Indonesia is responsible for developing and implementing all healthcare policies, including those relating to the use and regulation of contraceptive methods.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.